Cognitive Behavioral Therapy for Chronic Pain in Adults With Cerebral

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to understand if cognitive behavioral therapy can improve pain-related thought patterns and pain-related impairment in adults with cerebral palsy.

Clinical Trial Description

The majority of adults with cerebral palsy have chronic pain. The investigators have found that communicative adults with cerebral palsy reporting the most pain-related impairment had clinically-elevated catastrophizing thought-patterns. Because of this, a treatment targeting pain-related catastrophizing thought patterns may help reduce pain-related impairment. One potential treatment is cognitive behavioral therapy for chronic pain (CBT-CP). To investigate the efficacy of CBT-CP on reducing pain-related impairment and catastrophizing thought patterns in communicative adults with cerebral palsy, investigators will conduct and compare evaluations before and after participants receive a combination of CBT-CP and pain education. CBT-CP involves weekly group-therapy sessions for 12 weeks. Pain education is comprised of 12 weeks of usual medical care in addition to being given an educational booklet on chronic pain. Participants will be randomly assigned to receive either pain education followed by CBT-CP (group 1; Education-CBT), or the reverse order (group 2; CBT-Education). Participants in both groups will be assessed at the beginning of the study (at baseline; prior to group assignment), and then once every 3 months during the 12-month duration of the study. After baseline, assessments two and three will occur immediately after the 12 week pain education/CBT intervention periods (3 and 6 months into study), while assessments four and five are follow-up questionnaires to assess post-treatment effects (9 and 12 months into study). This study will be conducted at the Kennedy Krieger Institute in Baltimore, Maryland, USA. 40 participants who meet all inclusion/exclusion criteria will be recruited. Participants must endorse the ability and willingness to participate in all assessment and group sessions regardless of randomization outcome. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06269926
Study type	Interventional
Source	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Contact	Paul Salib, B.S
Phone	(443) 923-9272
Email	salib@kennedykrieger.org
Status	Not yet recruiting
Phase	N/A
Start date	May 2024
Completion date	April 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05317234` - Genetic Predisposition in Cerebral Palsy	N/A
Recruiting	`NCT05576948` - Natural History of Cerebral Palsy Prospective Study
Completed	`NCT04119063` - Evaluating Wearable Robotic Assistance on Gait	Early Phase 1
Completed	`NCT03264339` - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy	N/A
Completed	`NCT05551364` - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy	N/A
Completed	`NCT03902886` - Independent Walking Onset of Children With Cerebral Palsy
Recruiting	`NCT05571033` - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy	N/A
Not yet recruiting	`NCT04081675` - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed	`NCT02167022` - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy	N/A
Completed	`NCT04012125` - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy	N/A
Enrolling by invitation	`NCT05619211` - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities	Phase 1
Completed	`NCT04489498` - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed	`NCT03677193` - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy	N/A
Completed	`NCT04093180` - Intensive Neurorehabilitation for Cerebral Palsy	N/A
Completed	`NCT02909127` - The Pediatric Eating Assessment Tool
Not yet recruiting	`NCT06377982` - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy	Phase 1
Not yet recruiting	`NCT06007885` - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.	N/A
Not yet recruiting	`NCT03183427` - Corpus Callosum Size in Patients With Pineal Cyst	N/A
Active, not recruiting	`NCT03078621` - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy	Phase 1/Phase 2
Completed	`NCT02897024` - A Comparison: High Intense Periodic vs. Every Week Therapy in Children With Cerebral Palsy (ACHIEVE)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Cognitive Behavioral Therapy for Chronic Pain in Adults With Cerebral Palsy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms